Production (Stage)
Glucose Health, Inc.
GLUC
$0.0928
$0.00222.43%
OTC PK
09/30/2022 | 06/30/2022 | 03/31/2022 | 09/30/2021 | ||
---|---|---|---|---|---|
Revenue | 340.70K | 364.00K | 213.80K | 234.90K | |
Total Other Revenue | -- | -- | -- | -- | |
Total Revenue | 340.70K | 364.00K | 213.80K | 234.90K | |
Cost of Revenue | 186.90K | 246.00K | 90.70K | 172.90K | |
Gross Profit | 153.80K | 118.00K | 123.10K | 62.00K | |
SG&A Expenses | 145.70K | 228.80K | 314.10K | 193.80K | |
Depreciation & Amortization | -- | -- | -- | -- | |
Other Operating Expenses | -- | -- | -- | -- | |
Total Operating Expenses | 332.60K | 474.90K | 404.90K | 366.70K | |
Operating Income | 8.10K | -110.80K | -191.00K | -131.70K | |
Income Before Tax | 8.10K | -110.80K | -191.00K | -131.70K | |
Income Tax Expenses | -- | -- | -- | -- | |
Earnings from Continuing Operations | 8.10K | -110.80K | -191.00K | -131.70K | |
Earnings from Discontinued Operations | -- | -- | -- | -- | |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | |
Net Income | 8.10K | -110.80K | -191.00K | -131.70K | |
EBIT | 8.10K | -110.80K | -191.00K | -131.70K | |
EBITDA | -- | -- | -- | -131.70K | |
EPS Basic | 0.00 | -0.01 | -0.02 | -0.01 | |
Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.01 | |
EPS Diluted | 0.00 | -0.01 | -0.02 | -0.01 | |
Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.01 | |
Average Basic Shares Outstanding | 13.85M | 13.85M | 13.85M | 13.85M | |
Average Diluted Shares Outstanding | 13.85M | 13.85M | 13.85M | 13.85M | |
Dividend Per Share | -- | -- | -- | -- | |
Payout Ratio | 310.49% | -22.67% | -13.15% | -19.07% |